News Outlets Examine Various Aspects Of Race For COVID-19 Vaccine, Therapeutics, Including Operation Warp Speed; IFFIm Vaccine Bond Sales; WHO Plan For Vaccine Insurance; Pharma Companies’ Actions; Vaccine Mistrust

Bloomberg: Inside Operation Warp Speed’s $18 Billion Sprint for a Vaccine (Baker/Koons, 10/29).

CNBC: Moderna says it’s preparing global launch of Covid vaccine as it takes in $1.1 billion in deposits (Lovelace, 10/29).

Financial Times: Vaccine bond sale raises $500m to fund immunization programs (Stubbington, 10/30).

Financial Times: Moderna rakes in over $1bn in deposits for potential Covid vaccine (Kuchler, 10/29).

New York Times: Gilead’s Covid-19 Drug Is Mediocre. It Will Be a Blockbuster Anyway (Thomas, 10/29).

POLITICO: The Covid vaccine’s tricky politics (Paun, 10/29).

Reuters: Under pressure, WHO plans COVID-19 vaccine insurance scheme for poor nations (Guarascio, 10/29).

SciDev.Net: Vaccine mistrust threatens COVID immunity (Castilhos, 10/29).

Washington Post: The Health 202: Biden could take over the largest vaccine effort in U.S. history (Cunningham/Ellerbeck, 10/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.